BELATACEPT COMPARED WITH CYCLOSPORINE IN RENAL ALLOGRAFT RECIPIENTS OF EXTENDED CRITERIA DONOR KIDNEYS: 3-YEAR OUTCOMES FROM THE PHASE III BENEFIT-EXT TRIAL

被引：0

作者：

Medina Pestana, J. ^{[1
]}

Grinyo, J. ^{[2
]}

Vanrenterghem, Y. ^{[3
]}

Becker, T. ^{[4
]}

Florman, S. ^{[5
]}

Lang, P. ^{[6
]}

Rial, M. del C. ^{[7
]}

Schnitzler, M. ^{[8
]}

Duan, T. ^{[9
]}

Block, A. ^{[9
]}

Durrbach, A. ^{[10
]}

机构：

[1] Hosp Rim & Hipertensao, Sao Paulo, Brazil

[2] Univ Hosp Bellvitge, Barcelona, Spain

[3] Univ Hosp Leuven, Louvain, Belgium

[4] Hannover Med Sch, D-30623 Hannover, Germany

[5] Mt Sinai Med Ctr, New York, NY 10029 USA

[6] Hop Henri Mondor, F-94010 Creteil, France

[7] Inst Nefrol, Buenos Aires, DF, Argentina

[8] St Louis Univ, St Louis, MO 63103 USA

[9] Bristol Myers Squibb Co, Princeton, NJ USA

[10] Hop Bicetre, Le Kremlin Bicetre, France

来源：

TRANSPLANT INTERNATIONAL | 2011年 / 24卷

关键词：

D O I：

暂无

中图分类号：

R61 [外科手术学];

学科分类号：

摘要：

引用

页码：51 / 51

页数：1

共 50 条

[31] Outcomes at 3-years in EBV plus Recipients of Deceased Donor Kidneys from Two Randomized Trials (BENEFIT and BENEFIT EXT) Comparing Belatacept vs Cyclosporine
Muehlbacher, Ferdinand
Durrbach, Antoine
Florman, Sander
Pestana, Jose Medina
Harler, Mary Beth
Larsen, Christian
SWISS MEDICAL WEEKLY, 2014, 144 : 23S - 23S
[32] Outcomes at 3-Years in EBV plus Recipients of Deceased Donor Kidneys From Two Randomized Trials (BENEFIT and BENEFIT EXT) Comparing Belatacept vs Cyclosporine
Muehlbacher, F.
Durrbach, A.
Florman, S.
Medina Pestana, J.
Harler, M.
Larsen, C.
TRANSPLANTATION, 2014, 98 : 455 - 455
[33] OUTCOMES AT 3-YEARS IN EBV plus RECIPIENTS OF DECEASED DONOR KIDNEYS FROM TWO RANDOMIZED TRIALS (BENEFIT AND BENEFIT EXT) COMPARING BELATACEPT VERSUS CYCLOSPORINE
Durrbach, A.
Muehlbacher, F.
Florman, S.
Pestana, J. Medina
Harler, M. B.
Larsen, C.
TRANSPLANT INTERNATIONAL, 2015, 28 : 7 - 7
[34] Outcomes at 3-Years in EBV plus Recipients of Deceased Donor Kidneys From Two Randomized Trials (BENEFIT and BENEFIT EXT) Comparing Belatacept vs Cyclosporine
Muehlbacher, F.
Durrbach, A.
Florman, S.
Medina Pestana, J.
Harler, M.
Larsen, C.
AMERICAN JOURNAL OF TRANSPLANTATION, 2014, 14 : 455 - 455
[35] FOUR-YEAR OUTCOMES BY DONOR TYPE FROM THE LONG-TERM EXTENSION OF THE BELATACEPT BENEFIT AND BENEFIT-EXT STUDIES
Durrbach, A.
Medina Pestana, J.
Becker, T.
Grinyo, J.
Lang, P.
Garcia, V. D.
Duan, T.
Florman, S.
TRANSPLANT INTERNATIONAL, 2012, 25 : 50 - 50
[36] Four-Year Outcomes by Donor Type from the Long-Term Extension of the Belatacept BENEFIT and BENEFIT-EXT Studies
Durrbach, A.
Medina Pestana, J.
Becker, T.
Grinyo, J.
Lang, P.
Garcia, V. D.
Agarwal, M.
Duan, T.
Florman, S.
TRANSPLANTATION, 2012, 94 (10) : 987 - 987
[37] 5-YEAR OUTCOMES BY DONOR TYPE FROM THE LONG-TERM EXTENSION OF THE BELATACEPT BENEFIT-EXT STUDY
Muehlbacher, Ferdinand
Florman, Sander
Zhang, Rubin
Lang, Philippe
Lehner, Frank
Massari, Pablo
Garcia, Valter D.
Pupim, Lara
Durrbach, Antoine
TRANSPLANT INTERNATIONAL, 2013, 26 : 92 - 92
[38] Efficacy and Safety Outcomes of Extended Criteria Donor Kidneys by Subtype: Subgroup Analysis of BENEFIT-EXT at 7 Years After Transplant
Florman, S.
Becker, T.
Bresnahan, B.
Chevaile-Ramos, A.
Carvalho, D.
Grannas, G.
Muehlbacher, F.
O'Connell, P. J.
Meier-Kriesche, H. U.
Larsen, C. P.
AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 (01) : 180 - 190
[39] Five-Year Outcomes by Donor Type from the Long-Term Extension of the Belatacept BENEFIT-EXT Study
Durrbach, A.
Florman, S.
Zhang, R.
Lang, P.
Lehner, F.
Massari, P.
Garcia, V.
Pupim, L.
Muehlbacher, F.
AMERICAN JOURNAL OF TRANSPLANTATION, 2013, 13 : 311 - 311
[40] Four-Year Outcomes by Donor Type from the Long-Term Extension of the Belatacept BENEFIT and BENEFIT-EXT Studies.
Durrbach, A.
Florman, S.
Zhang, R.
Becker, T.
Grinyo, J.
Lang, P.
Garcia, V. D.
Duan, T.
Pupim, L.
Medina Pestana, J.
AMERICAN JOURNAL OF TRANSPLANTATION, 2012, 12 : 407 - 407

← 1 2 3 4 5 →